Literature DB >> 29287201

miR-365 functions as a tumor suppressor by directly targeting CYR61 in osteosarcoma.

Yawei Xu1, Haijiao Chu1, Yan Zhou1, Junling Wang1, Changying Dong1, Rui Yin2.   

Abstract

Increasing evidence indicates that microRNAs(miRNAs) are often aberrantly expressed in osteosarcoma (OS) and play critical roles in OS tumorigenesis. Therefore, the discovery of miRNAs may provide a new and powerful tool for understanding the mechanismof OS initiation and development. The aim of this study was to investigate the functional significance of miR-365 and identify its possible mechanism in OS cells. Here, wefound that the expression level of miR-365 is significantly downregulated in OS tissues and cell lines, and its expression isassociated with the clinical stage, distant metastasis, tumor grade, and poor overall survival rate. The overexpression of miR-365 is able to inhibit cell proliferation, migration, and invasion in Saos-2 and MG-63 cells. Moreover, the cysteine-rich angiogenic inducer 61 (CYR61) has been identified as a target of miR-365 in OS cells, and its expression is found to be significantly increased in OS tissues, which is negatively correlated with miR-365. Furthermore, CYR61 overexpression significantly attenuated the suppressive effects of miR-365 on the proliferation, migration, and invasion of Saos-2 and MG-63 cells. Therefore, we consider that miR-365 acts as a tumor suppressor in OS, partly, by targeting CYR61 expression.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  CYR61; Invasion; Osteosarcoma; Proliferation; miR-365

Mesh:

Substances:

Year:  2017        PMID: 29287201     DOI: 10.1016/j.biopha.2017.12.086

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  9 in total

Review 1.  miRNA signatures in childhood sarcomas and their clinical implications.

Authors:  G M Viera; K B Salomao; G R de Sousa; M Baroni; L E A Delsin; J A Pezuk; M S Brassesco
Journal:  Clin Transl Oncol       Date:  2019-04-04       Impact factor: 3.405

Review 2.  Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies.

Authors:  Wen-Xiu Xu; Dan-Dan Wang; Zhi-Qiang Zhao; He-Da Zhang; Su-Jin Yang; Qian Zhang; Lei Li; Jian Zhang
Journal:  Cancer Cell Int       Date:  2022-05-16       Impact factor: 6.429

Review 3.  The CCN axis in cancer development and progression.

Authors:  Herman Yeger; Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2021-04-20       Impact factor: 5.782

4.  miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.

Authors:  Ze-Bin Jiang; Bing-Qiang Ma; Zongfeng Feng; Shao-Guang Liu; Peng Gao; Hui-Ting Yan
Journal:  Cell Cycle       Date:  2021-01-18       Impact factor: 4.534

5.  Analysis of a Preliminary microRNA Expression Signature in a Human Telangiectatic Osteogenic Sarcoma Cancer Cell Line.

Authors:  Gaia Palmini; Cecilia Romagnoli; Simone Donati; Roberto Zonefrati; Gianna Galli; Francesca Marini; Teresa Iantomasi; Alessandra Aldinucci; Gigliola Leoncini; Alessandro Franchi; Giovanni Beltrami; Domenico Andrea Campanacci; Rodolfo Capanna; Maria Luisa Brandi
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

6.  Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.

Authors:  Xiaohui Hua; Daimin Xiang; Mengxin Guo; Xiaohui Qian; Ruifan Chen; Tengda Li; Zhongxian Tian; Jiheng Xu; Chao Huang; Qipeng Xie; Chuanshu Huang
Journal:  Cell Death Dis       Date:  2022-08-31       Impact factor: 9.685

7.  Analysis of the expression levels and clinical value of miR-365 and miR-25 in serum of patients with non-small cell lung cancer.

Authors:  Dongxuan Huang; Wenfang Ou; Huifen Tong; Ming Peng; Yamei Ou; Zeqing Song
Journal:  Oncol Lett       Date:  2020-09-03       Impact factor: 2.967

8.  miR-365 regulates liver cancer stem cells via RAC1 pathway.

Authors:  Ze-Bin Jiang; Bing-Qiang Ma; Shao-Guang Liu; Jing Li; Guang-Ming Yang; Ya-Bo Hou; Ruo-Huang Si; Peng Gao; Hui-Ting Yan
Journal:  Mol Carcinog       Date:  2018-10-05       Impact factor: 4.784

Review 9.  CCN proteins in the musculoskeletal system: current understanding and challenges in physiology and pathology.

Authors:  Veronica Giusti; Katia Scotlandi
Journal:  J Cell Commun Signal       Date:  2021-07-06       Impact factor: 5.782

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.